Stem cells are immature cells that have the ability to develop into bone, cartilage, muscle, tendon, or ligament. These mesenchymal stem cells (MSCs) can be taken from either bone marrow or fat (adipose) tissue. Either of these techniques can be performed in the office.
The objective of the stem cell procedures is to harness the natural regenerative ability of tissues and use that to treat orthopedic conditions. These cells are injected into an injured area, such as an arthritic knee joint, with the goal of reducing pain and improving function.
All autologous stem cell procedures using the patient’s own cells, and are done with minimal manipulation of the cells, according to FDA guidelines. The procedures are performed as a same-day procedure, with cells being harvested, isolated and injected within a period of a few hours.
More severe muscle, ligament and tendon tears, moderate to severe joint arthritis, and degenerative joint conditions. Patient with mild arthritis tend to show greater improvements than do patients with higher-grade or more severe arthritis.
Mesenchymal Stem Cells (MSCs) are a special type of cell that can differentiate and develop into different types of cells depending on the signals they receive from surrounding tissues. MSCs can become bone cells (osteoblasts), cartilage cells (chondrocytes), fat cells (adipocytes) or muscle cells (myocytes).
MSCs have been used in orthopedics for more than two decades, and injection of autologous stem cells to treat arthritis has shown improvement in pain and function.
Studies have shown benefit using both bone marrow derived stem cells (BMA) and adipose-derived MSCs. Published registry data of more than 2,000 patients shows favorable safety data with injectable MSCs for osteoarthritis.
Bone marrow aspiration (BMA) is performed using a trocar (needle) to remove the liquid portion of the bone marrow. Ultrasound is used to guide the needle, and ensure the cells from the ideal portion of the pelvis. Cells are obtained multiple locations to ensure maximize the number of cells obtained, and the stem cells concentrated using a centrifuge.
Adipose derived stem cells are processed using Lipogems technology. READ MORE (add link here to Lipogems page)
We use musuloskeletal ultrasound to identify the injured tendon, ligament or joint, and to guide the needle for the injection.
Most patients will need only one procedure when treating severe tendon or ligament injuries.
To treat arthritis more than one injection is sometimes needed.
Stem cell procedures are too new to be covered by insurance. Insurance plans typically cover the initial consultation, follow up appointments and therapy. Our billing department can answer questions regarding cost.